Summary & Overview
CPT 81443: Genetic Testing Panel for Severe Inherited Conditions
CPT code 81443 represents a comprehensive genetic testing panel for severe inherited conditions, including cystic fibrosis, Ashkenazi Jewish‑associated disorders, beta hemoglobinopathies, phenylketonuria, and galactosemia. This code is significant nationally as it enables early detection and diagnosis of a wide range of genetic disorders, supporting clinical decision-making and patient management. The panel requires sequencing of at least 15 genes, ensuring broad coverage for conditions with complex genetic backgrounds.
Major payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. The publication provides insights into payer coverage policies, billing benchmarks, and recent policy updates relevant to molecular pathology and genomic sequencing services. Readers will gain an understanding of the clinical context for CPT 81443, including its role in genetic screening and the types of conditions it addresses. The summary also highlights common billing practices and the importance of accurate coding for reimbursement.
This article is designed for healthcare professionals, billing specialists, and policy analysts seeking up-to-date information on genetic testing codes, payer coverage, and evolving trends in molecular diagnostics. It offers a clear overview of the code's clinical applications, payer landscape, and key considerations for billing and compliance.
CPT Code Overview
CPT 81443 is used for genetic testing targeting severe inherited conditions, including disorders such as cystic fibrosis, Ashkenazi Jewish‑associated syndromes (for example, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay‑Sachs disease), beta hemoglobinopathies, phenylketonuria, and galactosemia. This code covers a genomic sequence analysis panel that must include sequencing of at least 15 genes, such as ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, and PAH.
Service type: Molecular pathology / Genomic sequencing.
Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with a family history of severe inherited conditions, such as cystic fibrosis or Ashkenazi Jewish-associated disorders, presents for genetic counseling. The clinician orders a comprehensive genomic sequencing panel to assess the risk of inherited diseases. The workflow involves collecting a blood or saliva sample, sending it to a molecular pathology laboratory, and performing sequencing of at least 15 genes relevant to severe inherited conditions. Results are reviewed by a geneticist or molecular pathologist and discussed with the patient and their family.
Coding Specifications
-
Modifier
GX: Used when a Voluntary Advance Beneficiary Notice of Noncoverage (ABN) is issued, indicating that Medicare will likely deny coverage for the service. -
Modifier
GY: Used when a Notice of Exclusion is issued, indicating that the service is statutorily excluded from Medicare coverage.
| Modifier Code | Description |
|---|---|
GX | Voluntary ABN issued — Medicare will likely deny |
GY | Statutorily excluded service — Notice of Exclusion issued |
- Associated Provider Taxonomies: Data not available in the input.
Related Diagnoses
Data not available in the input.
Related CPT Codes
Data not available in the input.
National Reimbursement Benchmarks
Nationally, the mean rate for CPT code 81443 among BUCA (average commercial) payers is $1,953.48, which is substantially higher than the Medicare rate. The highest mean rate among individual commercial payers is from Cigna at $2,150.03, while Aetna is the lowest at $1,851.18.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Cigna exhibits the widest spread ($1,717.25), indicating significant variability in contracted rates. UnitedHealth Group has a range of $1,127.00, and Blue Cross Blue Shield shows a range of $1,079.00. Aetna has the tightest range at $710.00, suggesting more consistent rates across providers.
The table and chart below present the full breakdown of national benchmarks for CPT code 81443 by payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.